Published in J Neurol on January 09, 2011
Cognitive aspects of freezing of gait in Parkinson's disease: a challenge for rehabilitation. J Neural Transm (Vienna) (2013) 1.20
Virtual sensory feedback for gait improvement in neurological patients. Front Neurol (2013) 0.86
Parkinson-related changes of activation in visuomotor brain regions during perceived forward self-motion. PLoS One (2014) 0.83
Recent advances in the diagnosis and treatment of balance disorders. J Neurol (2011) 0.81
Movement visualisation in virtual reality rehabilitation of the lower limb: a systematic review. Biomed Eng Online (2016) 0.81
Effect of visual feedback on the occipital-parietal-motor network in Parkinson's disease with freezing of gait. Front Neurol (2014) 0.78
Acute and Chronic Effect of Acoustic and Visual Cues on Gait Training in Parkinson's Disease: A Randomized, Controlled Study. Parkinsons Dis (2015) 0.78
Virtual reality feedback cues for improvement of gait in patients with Parkinson's disease. Tremor Other Hyperkinet Mov (N Y) (2014) 0.78
Randomized controlled trial protocol: balance training with rhythmical cues to improve and maintain balance control in Parkinson's disease. BMC Neurol (2015) 0.75
Loss of visual feedback revealing motor impairment - an early symptom of Parkinson's disease in two Irish farmers. J Clin Mov Disord (2016) 0.75
Auditory and visual cueing modulate cycling speed of older adults and persons with Parkinson's disease in a Virtual Cycling (V-Cycle) system. J Neuroeng Rehabil (2016) 0.75
Effect of three cueing devices for people with Parkinson's disease with gait initiation difficulties. Gait Posture (2015) 0.75
Usability of Three-dimensional Augmented Visual Cues Delivered by Smart Glasses on (Freezing of) Gait in Parkinson's Disease. Front Neurol (2017) 0.75
Parkinsonism: onset, progression and mortality. Neurology (1967) 36.06
Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry (1992) 33.67
Falls and freezing of gait in Parkinson's disease: a review of two interconnected, episodic phenomena. Mov Disord (2004) 4.48
Cueing training in the home improves gait-related mobility in Parkinson's disease: the RESCUE trial. J Neurol Neurosurg Psychiatry (2007) 3.60
Construction of freezing of gait questionnaire for patients with Parkinsonism. Parkinsonism Relat Disord (2000) 2.70
Rhythmic auditory-motor facilitation of gait patterns in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (1997) 2.62
The pathogenesis of gait hypokinesia in Parkinson's disease. Brain (1994) 2.40
Gait dynamics in Parkinson's disease: relationship to Parkinsonian features, falls and response to levodopa. J Neurol Sci (2003) 2.37
Rhythmic auditory stimulation in gait training for Parkinson's disease patients. Mov Disord (1996) 2.31
Characterization of freezing of gait subtypes and the response of each to levodopa in Parkinson's disease. Eur J Neurol (2003) 2.17
Evidence for lateral premotor and parietal overactivity in Parkinson's disease during sequential and bimanual movements. A PET study. Brain (1997) 2.15
Motor blocks in Parkinson's disease. Neurology (1992) 2.01
Quality of life in Parkinson's disease: the relative importance of the symptoms. Mov Disord (2008) 1.92
Effects of external rhythmical cueing on gait in patients with Parkinson's disease: a systematic review. Clin Rehabil (2005) 1.91
Impaired regulation of stride variability in Parkinson's disease subjects with freezing of gait. Exp Brain Res (2003) 1.88
Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study. Ann Neurol (1992) 1.86
Abnormalities of the spatiotemporal characteristics of gait at the onset of freezing in Parkinson's disease. Mov Disord (2001) 1.59
Kick and rush: paradoxical kinesia in Parkinson disease. Neurology (2008) 1.59
Stride length regulation in Parkinson's disease: the use of extrinsic, visual cues. Brain (2000) 1.52
Effects of visual and auditory cues on gait in individuals with Parkinson's disease. J Neurol Sci (2004) 1.50
Understanding and treating freezing of gait in parkinsonism, proposed working definition, and setting the stage. Mov Disord (2008) 1.50
The effect of external rhythmic cues (auditory and visual) on walking during a functional task in homes of people with Parkinson's disease. Arch Phys Med Rehabil (2005) 1.45
Attending to the task: interference effects of functional tasks on walking in Parkinson's disease and the roles of cognition, depression, fatigue, and balance. Arch Phys Med Rehabil (2004) 1.44
Sensory cueing effects on maximal speed gait initiation in persons with Parkinson's disease and healthy elders. Gait Posture (2004) 1.34
The role of gait rhythmicity and bilateral coordination of stepping in the pathophysiology of freezing of gait in Parkinson's disease. Mov Disord (2008) 1.32
Postural instability in Parkinson's disease: a comparison with and without a concurrent task. Gait Posture (2000) 1.29
Visual control of locomotion in Parkinson's disease. Brain (1999) 1.25
The use of rhythmic auditory cues to influence gait in patients with Parkinson's disease, the differential effect for freezers and non-freezers, an explorative study. Disabil Rehabil (2006) 1.24
Quantification of trunk rotations during turning and walking in Parkinson's disease. Clin Neurophysiol (2007) 1.22
The factors that induce or overcome freezing of gait in Parkinson's disease. Behav Neurol (2008) 1.19
Effect of step-synchronized vibration stimulation of soles on gait in Parkinson's disease: a pilot study. J Neuroeng Rehabil (2006) 1.17
Cueing for freezing of gait in patients with Parkinson's disease: a rehabilitation perspective. Mov Disord (2008) 1.16
Auditory cues can modify the gait of persons with early-stage Parkinson's disease: a method for enhancing parkinsonian walking performance? Clin Rehabil (2003) 1.15
Effects of visual and auditory cues on gait initiation in people with Parkinson's disease. Clin Rehabil (2006) 1.15
The immediate effect of attentional, auditory, and a combined cue strategy on gait during single and dual tasks in Parkinson's disease. Arch Phys Med Rehabil (2007) 1.11
Temporal variability of gait in Parkinson disease: effects of a rehabilitation programme based on rhythmic sound cues. Parkinsonism Relat Disord (2004) 1.10
Enhanced lateral premotor activity during paradoxical gait in Parkinson's disease. Ann Neurol (1999) 1.10
Short-term and practice effects of metronome pacing in Parkinson's disease patients with gait freezing while in the 'on' state: randomized single blind evaluation. Parkinsonism Relat Disord (2004) 1.05
On the nature of fear of falling in Parkinson's disease. Behav Neurol (2011) 1.04
Visual kinesthesia and locomotion in Parkinson's disease. Mov Disord (2005) 1.04
The effects of pulsed auditory stimulation on various gait measurements in persons with Parkinson's Disease. NeuroRehabilitation (2002) 1.02
Freezing phenomenon in patients with parkinsonian syndromes. Mov Disord (1997) 1.00
Effect of rhythmic auditory stimulation on gait in Parkinsonian patients with and without freezing of gait. PLoS One (2010) 0.96
Gait festination and freezing in Parkinson's disease: pathogenesis and rehabilitation. Mov Disord (2008) 0.95
Akinetic freezing and trick movements in Parkinson's disease. J Neural Transm Suppl (1980) 0.94
Freezing gait in Parkinson's disease. Eur Neurol (1997) 0.91
Effects of stereotactic neurosurgery on postural instability and gait in Parkinson's disease. Mov Disord (2004) 0.90
Freezing of gait after bilateral subthalamic nucleus stimulation for Parkinson's disease. Clin Neurol Neurosurg (2005) 0.82
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology (1996) 12.33
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology (1996) 8.82
Geographic variation in human mitochondrial DNA from Papua New Guinea. Genetics (1990) 5.44
What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatry (2000) 4.66
Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain (2005) 4.33
Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet (1999) 3.94
Slater revisited: 6 year follow up study of patients with medically unexplained motor symptoms. BMJ (1998) 3.41
Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders. J Neurosurg (1996) 3.37
Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain (1994) 2.77
Positron emission tomography studies on the dopaminergic system and striatal opioid binding in the olivopontocerebellar atrophy variant of multiple system atrophy. Ann Neurol (1995) 2.76
High frequencies of alpha-thalassaemia are the result of natural selection by malaria. Nature (1986) 2.68
Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain (1992) 2.64
Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord (1997) 2.61
Distribution of ADH2 and ALDH2 genotypes in different populations. Hum Genet (1992) 2.55
Stimulation of the pre-SMA influences cerebral blood flow in frontal areas involved with inhibitory control of action. Brain Stimul (2013) 2.42
The dystonias. BMJ (1990) 2.29
How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population. Mov Disord (2000) 2.23
Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology (2000) 2.19
Clinical usefulness of magnetic resonance imaging in multiple system atrophy. J Neurol Neurosurg Psychiatry (1998) 2.19
Cross sectional prevalence survey of idiopathic Parkinson's disease and Parkinsonism in London. BMJ (2000) 2.17
Rate of sequence divergence estimated from restriction maps of mitochondrial DNAs from Papua New Guinea. Cold Spring Harb Symp Quant Biol (1986) 2.13
Cannot ventilate, difficult to intubate. Eur J Anaesthesiol (2006) 2.01
Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology (2001) 1.95
p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res (1994) 1.94
The bcl-3 proto-oncogene encodes a nuclear I kappa B-like molecule that preferentially interacts with NF-kappa B p50 and p52 in a phosphorylation-dependent manner. Mol Cell Biol (1993) 1.93
The EQ-5D--a generic quality of life measure-is a useful instrument to measure quality of life in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (2000) 1.89
MRI-guided STN DBS in Parkinson's disease without microelectrode recording: efficacy and safety. J Neurol Neurosurg Psychiatry (2010) 1.84
Binding and suppression of the Myc transcriptional activation domain by p107. Science (1994) 1.84
Self-initiated versus externally triggered movements. II. The effect of movement predictability on regional cerebral blood flow. Brain (2000) 1.75
Accuracy of self-reported disability in patients with parkinsonism. Arch Neurol (1989) 1.73
Severe tongue protrusion dystonia: clinical syndromes and possible treatment. Neurology (2006) 1.72
Ramsay Hunt syndrome and coeliac disease: a new association? Mov Disord (1986) 1.69
Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period [corrected]. Eur J Cancer (2005) 1.67
cDNA sequence, protein structure, and chromosomal location of the human gene for poly(ADP-ribose) polymerase. Proc Natl Acad Sci U S A (1987) 1.66
The natural history of tardive dystonia. A long-term follow-up study of 107 cases. Brain (1998) 1.65
Gastroduodenitis. A broader concept of peptic ulcer disease. Dig Dis Sci (1980) 1.59
Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann Neurol (1999) 1.57
Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. Brain (1998) 1.56
Tau gene and Parkinson's disease: a case-control study and meta-analysis. J Neurol Neurosurg Psychiatry (2004) 1.56
Genetic diagnosis in Lafora disease: genotype-phenotype correlations and diagnostic pitfalls. Neurology (2007) 1.53
Atypical and typical cranial dystonia following dental procedures. Mov Disord (1999) 1.49
Water intoxication due to carbamazepine. Br Med J (1977) 1.48
Long-term electrical inhibition of deep brain targets in movement disorders. Mov Disord (1998) 1.47
Strength in Parkinson's disease: relationship to rate of force generation and clinical status. Ann Neurol (1996) 1.47
Ataxia without telangiectasia masquerading as benign hereditary chorea. Mov Disord (1996) 1.45
(+)-4-Propyl-9-hydroxynaphthoxazine in Parkinson's disease. Lancet (1986) 1.45
Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. Cancer Res (1993) 1.44
Effects of subthalamic stimulation on speech of consecutive patients with Parkinson disease. Neurology (2010) 1.44
Inhibition of levodopa effects by internal pallidal stimulation. Mov Disord (1998) 1.42
The relationship of multiple system atrophy to sporadic olivopontocerebellar atrophy and other forms of idiopathic late-onset cerebellar atrophy. Neurology (1996) 1.41
Time estimation and reproduction is abnormal in Parkinson's disease. Brain (1992) 1.40
Essential tremor: an overdiagnosed condition? J Neurol (2000) 1.40
Clinical characteristics and topography of lesions in movement disorders due to thalamic lesions. Neurology (2001) 1.39
Clinical drug monitoring by microdialysis: application to levodopa therapy in Parkinson's disease. Br J Clin Pharmacol (1996) 1.39
Hemiballism and chorea in a patient with parkinsonism due to a multisystem degeneration. Mov Disord (1992) 1.39
Neurodevelopmental effects of the FMR-1 full mutation in humans. Nat Med (1995) 1.35
The value of urethral sphincter electromyography in the differential diagnosis of parkinsonism. Br J Urol (1989) 1.32
Painful Parkinson's disease. Lancet (1986) 1.31
Neurodevelopmental effects of X monosomy: a volumetric imaging study. Ann Neurol (1995) 1.31
Clinical features and natural history of axial predominant adult onset primary dystonia. J Neurol Neurosurg Psychiatry (1997) 1.29
Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann Neurol (1997) 1.29
What contributes to depression in Parkinson's disease? Psychol Med (2001) 1.29
Clinicopathological study of 35 cases of multiple system atrophy. J Neurol Neurosurg Psychiatry (1995) 1.28
Paroxysmal kinesigenic choreoathetosis: a report of 26 patients. J Neurol (1999) 1.28
Tumour-specific inhibition of lymphoma growth by an antisense oligodeoxynucleotide. Lancet (1990) 1.28
Repair of nonreplicating UV-irradiated DNA: cooperative dark repair by Escherichia coli uvr and phr functions. J Bacteriol (1985) 1.27
Dementia and Parkinson's disease--pathological and neurochemical considerations. Br Med Bull (1986) 1.27
Parkinson's disease. Br Med J (Clin Res Ed) (1986) 1.23
Visuospatial memory deficits at different stages of Parkinson's disease. Neuropsychologia (1993) 1.23
Opposite motor effects of pallidal stimulation in Parkinson's disease. Ann Neurol (1998) 1.23
Nerve conduction studies, skeletal muscle EMG, and sphincter EMG in multiple system atrophy. J Neurol Neurosurg Psychiatry (1995) 1.22
A role for deregulated c-Myc expression in apoptosis of Epstein-Barr virus-immortalized B cells. Proc Natl Acad Sci U S A (1994) 1.22
Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction. J Neurol Neurosurg Psychiatry (1994) 1.21
Cognitive performance in multiple system atrophy. Brain (1992) 1.21
The factors that induce or overcome freezing of gait in Parkinson's disease. Behav Neurol (2008) 1.19
Autonomic dysfunction in pathologically confirmed multiple system atrophy and idiopathic Parkinson's disease--a retrospective comparison. Acta Neurol Scand (1995) 1.19
Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain (2000) 1.18
Neurological complications associated with parenteral treatment: central pontine myelinolysis and Wernicke's encephalopathy. Br Med J (Clin Res Ed) (1986) 1.18
Treatment of tremor in Parkinson's disease by subthalamic nucleus stimulation. Mov Disord (1998) 1.17
Absence of antibodies to cardiolipin in patients with Huntington's chorea, Sydenhams chorea and acute rheumatic fever. J Neurol Neurosurg Psychiatry (1988) 1.17
Changes in forearm reciprocal inhibition following pallidal stimulation for dystonia. Neurology (2006) 1.17
Survival of patients with pathologically proven multiple system atrophy: a meta-analysis. Neurology (1997) 1.16
CDIP-58 can measure the impact of botulinum toxin treatment in cervical dystonia. Neurology (2006) 1.16
Deep brain stimulation of the subthalamic nucleus for Parkinson's disease: methodologic aspects and clinical criteria. Neurology (2000) 1.16
Sexual function in patients with Parkinson's disease and their partners. J Neurol Neurosurg Psychiatry (1990) 1.15
Parkinsonian impairment correlates with spatially extensive subthalamic oscillatory synchronization. Neuroscience (2010) 1.15
The fragile X tremor ataxia syndrome in the differential diagnosis of multiple system atrophy: data from the EMSA Study Group. Brain (2005) 1.14
Sequential bilateral transplantation in Parkinson's disease: effects of the second graft. Brain (1999) 1.14
Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data. Neurology (2008) 1.14
Interference with performance of a response selection task that has no working memory component: an rTMS comparison of the dorsolateral prefrontal and medial frontal cortex. J Cogn Neurosci (2001) 1.14
Is the neuropathology of new variant Creutzfeldt-Jakob disease and kuru similar? Lancet (1997) 1.14
What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease? J Neurol Neurosurg Psychiatry (2000) 1.14
Multiple system atrophy/progressive supranuclear palsy: alpha-Synuclein, synphilin, tau, and APOE. Neurology (2000) 1.13